Navigation Links
Number of Testosterone Therapy Lawsuits More than Doubles in Two-Week Period, Baron and Budd Reports
Date:7/18/2014

DALLAS (PRWEB) July 18, 2014

The number of lawsuits filed involving plaintiffs claiming they suffered adverse health affects after taking drugs associated with testosterone therapy more than doubled from June 6-16, 2014, reports the national law firm of Baron and Budd. On June 6 there were 45 such lawsuits pending in the U.S. District Court of Illinois, but by June 16 there were nearly 100 lawsuits pending. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

A Transfer Order was issued on June 6 by the U.S. Judicial Panel on Multidistrict Litigation (MDL), to consolidate lawsuits to facilitate more efficient progression of the cases. According to the Order, thousands more testosterone lawsuits could potentially be filed. (http://www.jpml.uscourts.gov/sites/jpml/files/MDL-2545-Initial_Transfer-05-14.pdf) Plaintiffs in the cases are claiming that the testosterone drugs they took caused a wide range of cardiovascular issues, including strokes and heart attacks.

The U.S. Food and Drug Administration announced on January 31, 2014 that it was undergoing a review of the medications in the wake of study results that showed a potential link between the drugs and the cardiovascular issues. These studies indicated that men taking testosterone therapy medications faced a higher chance of developing health problems than men who did not take the drugs. (http://www.fda.gov/Drugs/DrugSafety/ucm383904.htm)

On June 20, 2014, the FDA announced it would require manufacturers of testosterone therapy medications to add a warning to their labeling regarding the potential formation of blood clots. The higher risk, according to the agency, is due to a condition known as polycythemia, which is an increase in red blood cell count. Testosterone drugs have been linked to the condition.

“This momentum in testosterone therapy lawsuits is an indication that the FDA is moving in the right direction with respect to making sure the public is warned,” said Stephen Blackburn attorney at the national law firm of Baron and Budd. “We hope the FDA will consider the number of clients alleging injuries as a result of testosterone replacement therapy and take an even closer look at the widespread use of testosterone.”

Please get in touch with the national law firm of Baron and Budd if you or someone close to you suffered a stroke, blood clots or other cardiovascular problems after undergoing testosterone therapy. Call Baron and Budd at 866-472-9108 or visit our website to learn more: http://baronandbudd.com/areas-of-practice/pharmaceuticals/testosterone-therapy/.

ABOUT BARON AND BUDD

The law firm of Baron and Budd, with offices in Dallas, Baton Rouge, Austin and Los Angeles, is a nationally recognized law firm with over 35 years of “Protecting What’s Right” for people, communities and businesses harmed by negligence. Baron & Budd’s size and resources enable the firm to take on large and complex cases. The firm represents individuals, governmental and business entities in areas as diverse as water contamination, Gulf oil spill, Qui Tam, California Proposition 65 violations, unsafe drugs and medical devices, Chinese drywall, deceptive advertising, consumer financial fraud, securities fraud and asbestos cancers such as mesothelioma.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12017016.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. CDC Finds Maine With Highest Number of Opiate Prescription Users
2. Long-term care must be improved to aid rising numbers with dementia, study finds
3. When it comes to numbers, culture counts
4. Safety in numbers: Moderate drinking in a group reduces attraction to risk
5. Study shows young men increasingly outnumber young women in rural Great Plains
6. Mass number-crunching may help crack Alzheimers disease code
7. Atypical form of Alzheimers disease may be present in a more widespread number of patients
8. Scientists discover a number of novel genetic defects which cause oesophageal cancer
9. Concerning number of kids have elevated cholesterol
10. Number of babies mom has may play role in future cardiovascular health
11. RI Hospital: Number of patients admitted with antibiotic-resistant infections is rising
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... June 23, 2016 Bracket , a leading ... next generation clinical outcomes platform, Bracket eCOA (SM) 6.0, ... June 26 – 30, 2016 in Philadelphia ... Clinical Outcome Assessment product of its kind to fully integrate ... Bracket eCOA 6.0 is a flexible platform for electronic ...
Breaking Medicine Technology: